Direktorat Registrasi ObatValid

RANITIDINE HCL

Claim this product
BPOM Number
GKL1621646417A1
Approved
21 November 2024
Expiry
29 December 2027
Form
TABLET SALUT SELAPUT; 167,417 MG

About This Registration

RANITIDINE HCL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1621646417A1. Its current registration status is Valid, with the licence valid until 29 December 2027. The product is registered to PHAROS INDONESIA - INDONESIA. BPOM first approved this registration in October 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 3 STRIP @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

RANITIDINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
PHAROS INDONESIA - INDONESIA holds 177 BPOM registrations
Manufacturer Scale
PHAROS INDONESIA - INDONESIA produces 177 registered products
Registration Age
Registered for 1 year, 10 months

FDA Cross-Reference

via openFDA
Generic Name
RANITIDINE
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
Purpose
Purpose Acid reducer

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1